Hospitalizations for valvular heart disease in chronic dialysis patients in the United States

Nephron

Volumn 92, Issue 1, 2002, Pages 43-50

  Abbott, Kevin C ^a,b   Agodoa, Lawrence Y ^c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

African American; Age; Aortic; Complications; Dialysis; Erythropoietin; Heart failure; Hospitalization; Mitral; USRDS; Valvular heart disease

Indexed keywords

ERYTHROPOIETIN;

ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOCARDITIS; FEMALE; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEGRO; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; REGRESSION ANALYSIS; RISK ASSESSMENT; SURVIVAL RATE; UNITED STATES; VALVULAR HEART DISEASE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; FEMALE; HEART VALVE DISEASES; HOSPITALIZATION; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENAL DIALYSIS; RISK FACTORS; UNITED STATES;

EID: 0036375274     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064476     Document Type: Article

References (40)

1. Calcification of the aortic valve in the dialyzed patient
2. Transesophageal echocardiographic spectrum of calcific mitral abnormalities in patients with end-stage renal disease
3. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
4. Arterial stiffening and vascular calcifications in end-stage renal disease
5. Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery
6. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?
7. Cardiac surgery in patients with end-stage renal disease: 10-Year experience
8. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management
9. Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism
10. Validation of comorbid conditions on the end-stage renal disease medical evidence report: The CHOICE study: Choices for healthy outcomes in caring for ESRD
11. Long-term medical complications in patients surviving > or = 5 years after liver transplant
12. Echocardiographic predictors of survival in low gradient aortic stenosis
13. Mitral valve repair in heart failure
14. Mortality after aortic valve replacement: Results from a nationally representative database
15. Predictors of outcome in severe, asymptomatic aortic stenosis
16. Current medical management of secondary hyperparathyroidism
17. Rapid progression of aortic stenosis and secondary hyperparathyroidism
18. Cardiac calcific deposits in patients with primary hyperparathyroidism: Preliminary results of a prospective echocardiographic study
19. Role of ageing, chronic renal failure and dialysis in the calcification of mitral annulus
20. Cardiac abnormalities in patients with primary hyperparathyroidism: Implications for follow-up
21. Cardiovascular surgery in blacks
22. Myocardial calcification and cardiac dysfunction in chronic renal failure
23. Calcification of the aortic arch: Risk factors and association with coronary heart disease, stroke, and peripheral vascular disease
24. Race is a major determinant of secondary hyperparathyroidism in uremic patients
25. Racial differences in survival of patients on dialysis
26. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone
27. Association of elevated serum PO(4), Ca × PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients
28. Hypoparathyroidism potentiates cardiovascular complications through disturbed calcium metabolism: Possible risk of vitamin D(3) analog administration in dialysis patients with end-stage renal disease
29. Valvular heart disease: Pathogenesis and racial susceptibility
30. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease
31. Elective coronary and valve surgery without blood transfusion in patients treated with recombinant human erythropoietin (epoetin-alpha)
32. Increasing erythropoietin dose overcomes inadequate erythropoietin response secondary to cardiac hemolysis
33. Cardiac valve replacement in patients on dialysis: Influence of prosthesis on survival
34. The risk of birth defects among children of Persian Gulf War veterans
35. ICD-9 code for palliative or terminal care
36. Possible influence of the prospective payment system on the assignment of discharge diagnoses for coronary heart disease
37. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial